2025
Clinical effectiveness of HPV vaccine by age at vaccination: a matched case-control study
Oliveira C, Shapiro E, Sheth S, Ellingson M, Johnson N, Sullivan E, Querec T, Unger E, Niccolai L. Clinical effectiveness of HPV vaccine by age at vaccination: a matched case-control study. The Lancet Regional Health - Americas 2025, 51: 101225. PMID: 41019517, PMCID: PMC12465035, DOI: 10.1016/j.lana.2025.101225.Peer-Reviewed Original ResearchHPV vaccinationCase-control studyHuman papillomavirusVaccine effectivenessClinical effectsDose of HPV vaccineHigh-grade cervical lesionsOdds ratioBenefits of HPV vaccinationEffectiveness of HPV vaccinationMultivariable conditional logistic regression modelsVaccine-eligible womenPap smear resultsHuman papillomavirus vaccineConfidence intervalsConditional logistic regression modelsCenters for Disease Control and PreventionDisease Control and PreventionCervical lesionsSmear resultsFirst doseHPV-16Pap testControl and PreventionLogistic regression models
2011
O1-S02.06 Detection of cervical cancer precursors and associated HPV types in the USA: HPV-IMPACT preliminary results
Powell S, Hariri S, Steinau M, Bauer H, Bennett N, Bloch K, Schafer S, Niccolai L, Unger E, Markowitz L. O1-S02.06 Detection of cervical cancer precursors and associated HPV types in the USA: HPV-IMPACT preliminary results. Sexually Transmitted Infections 2011, 87: a25. DOI: 10.1136/sextrans-2011-050109.12.Peer-Reviewed Original ResearchHPV typesVaccine impactCervical intraepithelial neoplasia grade 2HPV vaccine impactMedian diagnosis ageCervical cancer precursorsMultiple HPV typesRoche Linear ArrayPreinvasive cervical lesionsProportion of lesionsHPV16 prevalenceHPV18 prevalenceCervical diseaseHPV DNAResidual lesionsDiagnosis ageCervical lesionsCancer precursorsDiagnostic blocksCase ascertainmentCIN2Grade 2Diagnosis rateFemales 18Type replacement
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply